Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Involvement
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joshua Reuss, MD
Georgetown University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Lombardi Comprehensive Cancer Center, Georgetown University
Washington D.C., District of Columbia, United States
Joshua Reuss, MDRecruiting - Washington University School of Medicine-Sitemen Cancer Center
St Louis, Missouri, United States
Ece Cali Daylan, MD, PhDRecruiting - Uva Comprehensive Cancer Center
Charlottesville, Virginia, United States
Ryan Gentzler, MD, MSRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2026
- Primary completion
- 31 Dec 2027
- Completion
- 30 Sept 2032
- Last update posted
- 10 Jun 2026
- Registered enrollment
- 21
- Registry id
- NCT06449313
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.